237 related articles for article (PubMed ID: 32267481)
1. Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV).
Lee JW; Choi E; Son JW; Youn YJ; Ahn SG; Ahn MS; Kim JY; Lee SH; Yoon J; Ryu DR; Park SM; Hong KS; Yoo BS
Am J Hypertens; 2020 Aug; 33(8):748-755. PubMed ID: 32267481
[TBL] [Abstract][Full Text] [Related]
2. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
[TBL] [Abstract][Full Text] [Related]
4. Effects of doxazosin mesylate versus nifedipine on blood pressure variability in hypertensive patients: a randomized crossover study (SIMILAR).
Shi J; Liang D; Pan Y; Zhang S; He M; Zhang H; Liu G; Gong Y; Wang W; Cang H; Li Y
Blood Press Monit; 2019 Oct; 24(5):252-258. PubMed ID: 31116151
[TBL] [Abstract][Full Text] [Related]
5. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy.
Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Matayoshi T; Takiuchi S; Kamide K; Nakamura S; Horio T
Clin Exp Hypertens; 2013; 35(4):279-84. PubMed ID: 23530977
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.
Volpe M; Junren Z; Maxwell T; Rodriguez A; Gamboa R; Gomez-Fernandez P; Ortega-Gonzalez G; Matadamas N; Rodriguez F; Dass B; Kyle C; Clarysse L; Bryce A; Moreno-Heredia E; Germano G; Gilles L; Smith RD; Sanderson JE;
Clin Ther; 2003 May; 25(5):1469-89. PubMed ID: 12867222
[TBL] [Abstract][Full Text] [Related]
7. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS;
Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347
[TBL] [Abstract][Full Text] [Related]
8. Effects of Different Antihypertensive Drug Combinations on Blood Pressure and Arterial Stiffness.
Jatic Z; Skopljak A; Hebibovic S; Sukalo A; Rustempasic E; Valjevac A
Med Arch; 2019 Jun; 73(3):157-162. PubMed ID: 31391706
[TBL] [Abstract][Full Text] [Related]
9. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
Wilson TW; Lacourcière Y; Barnes CC
CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
Lee HY; Kim SY; Choi KJ; Yoo BS; Cha DH; Jung HO; Ryu DR; Choi JH; Lee KJ; Park TH; Oh JH; Kim SM; Choi JY; Kim KH; Shim J; Kim WS; Choi SW; Park DG; Song PS; Hong TJ; Rhee MY; Rha SW; Park SW
Clin Ther; 2017 Dec; 39(12):2366-2379. PubMed ID: 29150250
[TBL] [Abstract][Full Text] [Related]
11. Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg.
Rakugi H; Tsuchihashi T; Shimada K; Numaguchi H; Nishida C; Yamaguchi H; Shirakawa M; Azuma K; Fujita KP
Hypertens Res; 2015 May; 38(5):329-35. PubMed ID: 25716649
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
Oparil S; Barr E; Elkins M; Liss C; Vrecenak A; Edelman J
Clin Ther; 1996; 18(4):608-25. PubMed ID: 8879890
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
14. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
Payeras AC; Sladek K; Lembo G; Alberici M
Clin Drug Investig; 2007; 27(9):623-32. PubMed ID: 17705571
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of blood pressure reduction response and responder characteristics to fixed-dose combination treatment of amlodipine and losartan: a post hoc analysis of pooled clinical trials.
Unniachan S; Wu D; Rajagopalan S; Hanson ME; Fujita KP
J Clin Hypertens (Greenwich); 2014 Sep; 16(9):671-7. PubMed ID: 25098858
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
19. Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
Wang JG; Yan P; Jeffers BW
J Am Soc Hypertens; 2014 May; 8(5):340-9. PubMed ID: 24685006
[TBL] [Abstract][Full Text] [Related]
20. Predictors of visit-to-visit blood pressure variability in patients with hypertension: an analysis of trials with an amlodipine treatment arm.
Wang JG; Zhou D; Jeffers BW
J Am Soc Hypertens; 2017 Jul; 11(7):402-411. PubMed ID: 28624170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]